Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Laurie L. Wakefield"'
Autor:
Ann M. Moyer, Shahrukh K. Hashmi, Cynthia M. Kroning, Mrinal Patnaik, Mark Litzow, Dennis A. Gastineau, William J. Hogan, Eapen K. Jacob, Justin D. Kreuter, Laurie L. Wakefield, Manish J. Gandhi
Publikováno v:
Leukemialymphoma.
To evaluate the impact of killer immunoglobulin-like receptor (KIR) genotyping in allogeneic hematopoietic stem cell transplantation for myeloid disorders at our institution, retrospective KIR genotyping was performed on 77 patients and their 10/10 m
Autor:
Laurie L. Wakefield, Rachel K. Horton, Justin E. Juskewitch, Micah D. Zuccarelli, Margaret A. DiGuardo, Manish J. Gandhi
Publikováno v:
Transfusion. 60:3055-3059
Prozone is a known phenomenon affecting immunoassays causing falsely low or negative results when excess target is present in the test system. For assays used to evaluate immune-mediated platelet (PLT) transfusion refractoriness, prozone-like phenome
Autor:
Laurie L. Wakefield, Manish J. Gandhi, Sarah E. Kerr, Bohdana Fedyshyn, Elizabeth Ann L. Enninga, Rodrigo Ruano, Svetomir N. Markovic, Alexey A. Leontovich
Publikováno v:
Reprod Sci
The placenta utilizes many mechanisms to protect the haploidentical fetus from recognition by the maternal immune system. However, in cases of villitis of unknown etiology (VUE), maternal lymphocytes gain access into the placenta, causing significant
Autor:
Laurie L. Wakefield, Kristie K. Clymer, Justin E. Juskewitch, Manish J. Gandhi, Justin D. Kreuter, Micah D. Zuccarelli
Publikováno v:
TransfusionREFERENCES. 61(11)
Solid-phase platelet crossmatch (PXM) testing is used to help manage patients with platelet transfusion-refractoriness. Recently, we published the first report of false-negative PXM results from prozone effect that was mitigated using sample dilution
Autor:
Laurie L. Wakefield, Justin E. Juskewitch, Manish J. Gandhi, Micah D. Zuccarelli, Holly E. Berg, Daniel D Summerfield
Publikováno v:
Transfusion. 61:9-11
Autor:
Manish J. Gandhi, Brittany Schneider, Rajeswari Avula, Matthew P. Goetz, Patti Duellman, Krishna R. Kalari, Ann M. Moyer, Jennifer M. Skierka, Brian A. Dukek, Laurie L. Wakefield, Aditya Bhagwate, Justin D. Kreuter, Judy C. Boughey, John L. Black
Publikováno v:
Hum Immunol
We explored the feasibility of obtaining accurate HLA type using pre-existing NGS data not generated for HLA purposes. 83 exomes and 500 targeted NGS pharmacogenomic panels were analyzed using Omixon HLA Explore, OptiType, and/or HLA-Genotyper softwa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dea00e033a72a200a1591c3c89a99203
https://europepmc.org/articles/PMC7721171/
https://europepmc.org/articles/PMC7721171/
Autor:
Manish J. Gandhi, Nisar A. Baig, Laurie L. Wakefield, Justin D. Kreuter, Aleh Bobr, Brian A. Dukek, Deborah K. Falbo, Margaret A. DiGuardo
Publikováno v:
Vox sanguinisReferences. 116(1)
Background Daratumumab (DARA), a human IgG1K monoclonal antibody targeting CD38, is used to treat refractory multiple myeloma patients. CD38 is expressed on many cell types (RBCs, granulocytes, lymphocytes, etc.), and thus, DARA can interfere with se
Autor:
Manish J. Gandhi, Laurie L. Wakefield, Byron H. Smith, Donald Mitema, Carrie A. Schinstock, M. Moreno Gonzales, Nicole Henderson, Mark D. Stegall, Steven R. DeGoey, Justin D. Kreuter
Publikováno v:
Transplantation Proceedings. 49:2031-2035
Complement-binding donor-specific antibodies (DSAs) are associated with antibody-mediated rejection and allograft loss. Novel single antigen bead (SAB) assays-that is, complement component 1q (C1q) and complement component 3d (C3d) assays-have been d
Autor:
Manish J. Gandhi, Laurie L. Wakefield, Patti Duellman, Justin D. Kreuter, Justin E. Juskewitch, Steven R. De Goey, Andrew P. Norgan, James R. Stubbs
Publikováno v:
Transfusion. 57:2828-2835
BACKGROUND Platelet transfusion–refractoriness is a challenging and expensive clinical scenario seen most often in patients with hematologic malignancies. Although the majority of platelet transfusion–refractory cases are due to nonimmune causes,
Autor:
Cynthia M. Kroning, Manish J. Gandhi, Mrinal M. Patnaik, Shahrukh K. Hashmi, William J. Hogan, Laurie L. Wakefield, Dennis A. Gastineau, Mark R. Litzow, Justin D. Kreuter, Eapen K. Jacob, Ann M. Moyer, Steven R. De Goey, Walter K. Kremers
Publikováno v:
European Journal of Haematology. 99:275-282
Objective HLA-DPB1 matching may impact allogeneic hematopoietic stem cell transplantation (ASCT) outcomes; however, this locus is not in linkage disequilibrium with the remainder of the HLA genes. After classifying HLA-DPB1 mismatches based on T-cell